South Central Ventures announces new investment in Virtus Vita

South Central Ventures is announcing its investment in Virtus Vita, a global dialysis & travel company with a vision to revolutionize the medical tourism sector with their state of the art medical booking platform.

The world population is growing and traveling across international borders with the intention of receiving some form of medical treatment is on the rise.

Therefore, in the past 10 years, medical tourism has become one the most dynamic and rapidly developing sectors of tourism.

Today, there are approximately 14 million annual cross-border patients worldwide, spending an average of USD 4,000-6,000 per visit. Every year patients demand better, faster and easier solutions making the Меdical Tourism market grow at CAGR 23% with a current market of $100 Billion and projected to reach $3 trillion by 2025.

Driven by the continuously increasing demand from consumers seeking healthcare abroad, Virtus Vita is launching the first-ever online booking platform in medical tourism,”boooknowmed”.



Real-time availabliity for booking treatments

Harvesting the potential of digital technology, “BookNowMed” will provide real-time availability for booking treatments; connecting medical travelers with the world’s largest network of medical facilities. Real-time availability will drastically simplify the current booking process from a number of days to a matter of minutes.

The company was originally founded in 2012 and has rapidly developed a leadership position in the field of renal healthcare and holiday dialysis. Today, the company has one of the largest online networks, counting 400+ clinics in 380 destinations worldwide; empowering renal patients to explore the world by securing their treatments when traveling.


Reshaping the booking process

Through partnerships with 60 National & Local Kidney Patient Associations in 20 countries, they have access to 1,2 million renal patients globally.

The impact of Booknowmed in completely reshaping the booking process, not only for renal healthcare but for a variety of specialized treatments, is the reason why this initiative has been supported and validated by Medical Associations worldwide, including the American Association of Kidney Patients (AAKP).

The founder and CEO of Virtus Vita Antonios-Aris Bailan was one of the first entrepreneurs to identify this niche market segment and the need to reshape the booking process for renal patients globally. Since 2012, the Virtus Vita team has been focusing on creating a worldwide network of clinics allowing patients to book their treatment online. For the upcoming investment Aris said:

“Our vision is for BNM to become the #1 online booking platform for medical tourism, making all steps of the booking process a stress-free experience for all.”

The investment in Virtus Vita will help the company launch their Booknowmed Platform and scale it worldwide.  “We are excited to work with Virtus Vita on digitalizing and scaling their booking platform. The company is obviously delivering enormous value to renal patients and is well-positioned to completely reshape this specific medical tourism niche” said Jan Kobler, managing partner at SCV.